XTorial With Patients and Caregivers (Q&A)

Share

Program Content

Activities

  • Novel ADCs in Breast Cancer
    Expert Perspectives on Novel and Emerging HER2-Directed and TROP-2‒Targeted ADCs for Advanced Breast Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 02, 2024

    Expires: May 01, 2025

Faculty

cover img faculity

Kevin Kalinsky, MD, MS

Division Director, Medical Oncology
Professor, Department of Hematology and Medical Oncology
Winship Cancer Institute at Emory University
Atlanta, Georgia

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.